PMV Pharmaceuticals, Inc.

NASDAQ:PMVP

1.74 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 0001.6180000000000000000000
Cost of Revenue 00.3720.3620.3590.3580.3690.0820.160.1440.1790.1670.4070.410.0710.07900000000
Gross Profit 0-0.372-0.3621.259-0.358-0.369-0.082-0.16-0.144-0.179-0.167-0.407-0.41-0.071-0.07900000000
Gross Profit Ratio 0000.7780000000000000000000
Reseach & Development Expenses 16.94714.25612.82413.02313.58613.84315.07315.02513.66611.46211.83612.1679.1627.6647.56.1815.9925.8045.9555.6994.8955.0835.083
General & Administrative Expenses 4.9415.5425.0355.526.0426.2796.4076.1375.7096.4236.7836.3055.9355.3864.1744.322.7092.2811.6991.6561.5451.3381.338
Selling & Marketing Expenses 00000000000000000000000
SG&A 4.9415.5425.0355.526.0426.2796.4076.1375.7096.4236.7836.3055.9355.3864.1744.322.7092.2811.6991.6561.5451.3381.338
Other Expenses 0-0.017-0.001-0.0210.004-0.0060.0270.020.013-0.031-0.0410.0070.0030.063-0.0520-0.1-0.039-0.0050000
Operating Expenses 21.88819.79817.85918.54319.62820.12221.4821.16219.37517.88518.61918.47215.09713.0511.67410.5018.7018.0857.6547.3556.446.4136.413
Operating Income -21.888-20.17-18.221-18.902-19.628-20.122-21.48-21.162-19.375-17.885-18.619-18.472-15.097-13.05-11.674-10.501-8.701-8.085-7.654-7.355-6.44-6.421-6.421
Operating Income Ratio 000-11.6820000000000000000000
Total Other Income Expenses Net 2.7362.7842.9513.1452.988-0.0062.3521.8171.1370.5730.1880.0070.0030.063-0.0520.048-0.1-0.039-0.0050.3080.2720.3650.365
Income Before Tax -19.152-17.386-15.27-15.757-16.64-17.432-19.128-19.345-18.238-17.312-18.431-18.359-14.992-12.874-11.598-10.453-8.761-7.967-7.253-7.047-6.168-6.056-6.056
Income Before Tax Ratio 000-9.7390000000000000000000
Income Tax Expense 0.074-16.1730.319-0.001-0.3580.004-2.352-0.018-0.009-0.0020.0020.0230.019-0.1130.0040.0010.003-0.1570.00200.0070.0010.001
Net Income -19.226-1.213-15.27-15.756-16.64-17.436-16.776-19.327-18.229-17.31-18.433-18.359-15.011-12.874-11.602-10.454-8.764-7.967-7.255-7.047-6.175-6.057-6.057
Net Income Ratio 000-9.7380000000000000000000
EPS -0.37-0.024-0.3-0.31-0.34-0.38-0.37-0.42-0.4-0.38-0.41-0.41-0.33-0.29-0.26-1.74-1.46-0.19-0.23-0.23-0.2-2-2
EPS Diluted -0.37-0.024-0.3-0.31-0.34-0.38-0.37-0.42-0.4-0.38-0.41-0.41-0.33-0.29-0.26-1.74-1.46-0.19-0.23-0.23-0.2-2-2
EBITDA -21.888-19.798-17.859-18.543-19.628-19.753-21.309-21.087-19.301-17.803-18.535-18.395-15.017-12.979-11.595-10.44-8.701-7.997-7.56-7.26-6.333-6.328-6.328
EBITDA Ratio 000-11.460000000000000000000